NEP-IN-2 is a neutral endopeptidase (NEP) inhibitor used in the research of atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis, and other diseases involving vascular cell proliferation.